Legend Biotech Corp is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LEGN is expected to report earnings to rise 29.94% to -20 cents per share on May 14
Q1'25
Est.
$-0.21
Q4'24
Beat
by $0.09
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.24
Q1'24
Beat
by $0.03
The last earnings report on March 11 showed earnings per share of -15 cents, beating the estimate of -25 cents. With 807.79K shares outstanding, the current market capitalization sits at 5.65B.